You just read:

Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

News provided by

Achieve Life Sciences, Inc.

Apr 02, 2019, 05:30 ET